Skip to content

Neogen NEOG Gross margin

Gross margin at other companies

Idexx Laboratories logo
Idexx LaboratoriesIDXX
62.1%+0.8pp
Zoetis logo
ZoetisZTS
71.8%+0.8pp
TEC
Bio-TechneTECH
65%-0.8pp
Agilent Technologies logo
Agilent TechnologiesA
52.7%-0.6pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
51.9%-1.6pp
Merck & Co. logo
Merck & Co.MRK
73.9%-2.5pp

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$1.92B+12.0%
Enterprise value$2.56B+4.4%
P/S2.2×+0.3×

Profitability

See full
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Calculated from Neogen’s reported figures.

Based on trailing twelve months.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's gross margin?
Neogen (NEOG) reported gross margin of 45.2% in Q4 2025.
How has Neogen's gross margin changed year-over-year?
Neogen's gross margin decreased by 7.3% year-over-year, from 48.8% to 45.2%.
What is the long-term trend for Neogen's gross margin?
Over 4 years (2021 to 2025), Neogen's gross margin has grown at a 0.6% compound annual growth rate (CAGR), from 45.9% to 47.1%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.